Why Tendons and Ligaments Get Hurt More Easily After Menopause, What the Collagen Research Shows

• Why do tendons and ligaments get hurt more easily after menopause?
• What did the direct human study on estrogen and tendon collagen find?
• Why is the estrogen-tendon evidence still uncertain?
• What does the shilajit collagen research show?
• How does this compare with rest, physical therapy, and hormone therapy?
• What can you do to protect tendons and ligaments day to day?
• Common questions about tendons, ligaments, and menopause

Why do tendons and ligaments get hurt more easily after menopause?

A tendon connects muscle to bone. A ligament connects bone to bone. Both are made almost entirely of type 1 collagen, arranged into dense, rope-like fibers that store and release energy with every step, lift, or throw. There is very little else in either tissue. Collagen is not a supporting player here, it is nearly the whole structure.

That single fact is why tendon and ligament health tracks so closely with anything that changes collagen production in the body, and estrogen is one of the clearest known regulators of collagen synthesis. Clinical experience backs this up long before the research does. Rotator cuff tears, Achilles tendinopathy, and plantar fasciitis all become measurably more common in the years around menopause, a pattern orthopedic and sports medicine literature has documented for years without fully explaining the mechanism behind it.

Why this is different from a joint or cartilage problem

Osteoarthritis is a cartilage and joint-lining problem. Frozen shoulder is a capsule problem. Tendon and ligament injury is neither. It is a structural failure in a collagen rope that has lost some of the manufacturing signal keeping it strong, which is a distinct mechanism worth understanding on its own terms.

What did the direct human study on estrogen and tendon collagen find?

A 2008 study, published in the Journal of Applied Physiology, went directly at this question in postmenopausal women rather than relying on inference. Researchers compared 10 women using estrogen replacement therapy against 10 women who were not, measuring tendon collagen synthesis directly through biopsy.

The result was clear on the synthesis side.

• Tendon collagen fractional synthesis rate was markedly higher in the estrogen-therapy group, a statistically significant difference (P < 0.001)
• Fibril composition differed between the groups, with more medium-sized collagen fibrils in the estrogen group
• Tendon stiffness, measured as Young's modulus, was lower in the estrogen-therapy group despite the higher synthesis rate

The estrogen group's tendons were both building more collagen and behaving less stiffly, a combination the study's authors read as evidence that estrogen shapes not just how much collagen gets made, but how it gets structured once it is there.

Why this is the most direct evidence available, and its real limits

This is a small study, 10 women per group, and it measured estrogen therapy, not shilajit or any supplement. It is included here because it is the clearest human data connecting estrogen decline specifically to tendon collagen behavior in postmenopausal women, which is the foundation the rest of this article builds on.

Why is the estrogen-tendon evidence still uncertain?

Honesty matters more than a tidy story here. A systematic review pooling the available human research found only 9 studies total on female sex hormones and tendon, 8 of them cross-sectional and 1 a randomized crossover trial.

The review's own conclusion is blunt. "The effect of oestrogen supplementation on tendon is contradictory and inconsistent," the authors wrote, calling for further research at the mechanical, structural, and molecular level before anything stronger can be claimed.

• Tendon collagen synthesis was consistently higher with hormone supplementation across the studies reviewed
• Mechanical properties, including stiffness and maximum tendon force, showed mixed and sometimes contradictory results
• Hormone-supplemented postmenopausal women showed a smaller Achilles tendon diameter in one study, a structural finding of unclear meaning on its own
• Most outcomes, taken as a whole, showed no significant difference between groups

This is early, real, human science, not a settled mechanism with a clean before-and-after story. We are stating that plainly rather than smoothing it over.

What does the shilajit collagen research show?

Shilajit has never been tested on tendon tissue directly in a clinical trial. What exists is human research on the same collagen-synthesis pathway the estrogen-tendon studies above were measuring, in different tissue.

An 8-week trial in 35 adults, run by Neltner and colleagues, measured Pro-C1α1, a blood marker of active type 1 collagen synthesis, the same collagen type that makes up tendon.

• Pro-C1α1 rose 94 percent at 500 milligrams of shilajit daily, and 165 percent at 1000 milligrams, both versus placebo
• Hydroxyproline, a marker of collagen breakdown, fell 29 percent at the 500 milligram dose
• The trial enrolled men, and measured overall collagen turnover, not tendon tissue specifically

A separate 8-week human trial in 16 adults, run by Das and colleagues, biopsied muscle tissue and found a cluster of structural genes activated together, including COL1A1 and COL1A2, the same 2 genes that build the fibrils measured in the estrogen-tendon study above.

The in vitro piece, and where it fits

One additional line of evidence comes from a laboratory study, not a human trial. Researchers found that fulvic acid, shilajit's principal active compound, dose-dependently increased type 2 collagen secretion from cartilage cells in a dish. This is cell-culture evidence in a different collagen type and a different tissue, cartilage rather than tendon, included here as mechanism support, not as tendon proof.

How does this compare with rest, physical therapy, and hormone therapy?

Rest and physical therapy remain the standard first response to an actual tendon or ligament injury once it happens, and nothing here changes that. Hormone therapy is the only approach with direct human tendon-collagen data, though the systematic review above shows that evidence itself is unsettled. Shilajit sits in a third position, a non-hormonal route to the same collagen-synthesis pathway, tested in different tissue.

Nobody has run the trial that would settle this cleanly, a shilajit tendon study in postmenopausal women measuring collagen synthesis and injury rate directly. Until that exists, the honest position is that all 3 approaches address a real piece of the picture, none of them the whole thing.

What can you do to protect tendons and ligaments day to day?

A handful of habits have solid, tendon-specific evidence behind them regardless of what future hormone or supplement research finds.

• Warm up gradually before activity, since cold tendon tissue tolerates load poorly compared to warmed tissue
• Progress load slowly in any new strength or activity program, since tendons adapt more slowly than muscle does
• Eat adequate protein daily, since amino acids are the raw material collagen synthesis depends on
• Add eccentric strength work for tendons that have felt tender or stiff, a well-studied approach for Achilles and patellar tendon issues specifically
• Do not push through sharp or localized pain, since that is the signal tendon tissue gives before a partial tear, not after

Shilajit's fulvic acid content supports the same collagen-synthesis pathway measured in the trials above, and it is the core ingredient in Optimum Shilajit, sourced from the Altai mountains and third-party tested for purity on every batch. No trial has tested shilajit on tendon or ligament tissue directly, and we say that plainly rather than imply a result the research has not shown.